Clinical Trials Browser

Interventional × Hyperglycemia × Clear all

NCT05455619 2026-04-22

Amelia-1

Phase 1/2 Recruiting

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance

NCT04662879 2026-03-12

EDI

Phase NA Active not recruiting

Diabetes Mellitus, Hyperglycemia, Weight Loss

NCT05132244 2025-09-22

PEGASUS

Phase NA Recruiting

Gastrointestinal

Hyperglycemia, Pancreatic Neoplasms

NCT04300790 2025-07-29

METALLICA

Phase 2 Completed

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT04899349 2024-10-09

EPIK-B4

Phase 2 Terminated

2 enrolled 8 charts

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

NCT04373265 2024-02-23

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

Phase 1 Completed

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, Diabetes Mellitus, Type 2, Endocrine System Diseases, Hyperglycemia, Hypertension, Pathologic Processes, Glucose Intolerance, Adrenocortical Carcinoma

NCT03904199 2023-01-20

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

Phase EARLY_PHASE1 Completed

Hyperglycemia

NCT04330625 2022-11-08

Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)

Phase 1 Terminated

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

NCT03978702 2022-01-06

IMMUNOPANC

Phase NA Unknown

Gastrointestinal

Hyperglycemia, Pancreatic Neoplasms

NCT05107388 2021-11-04

AAREN

Phase NA Unknown

Breast Neoplasms, Diabetes Mellitus, Hyperglycemia

NCT04253223 2021-06-11

A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

Phase 1 Terminated

Hyperglycemia, Lymphoma

NCT00910988 2018-07-18

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Phase NA Completed

46 enrolled 38 charts

Hyperglycemia, Hyperlipidemias, Insulin Resistance, Multiple Endocrine Neoplasia Type 1, Sedentary Behavior

NCT02012465 2018-05-07

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Phase EARLY_PHASE1 Completed

Diabetes Mellitus, Type 2, Hyperglycemia, Lymphoma

NCT02248272 2017-10-04

Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes

Phase NA Completed

Diabetes Mellitus, Type 2, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance

NCT02216799 2016-02-25

GLUCOSE-in-PN

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

NCT00500240 2015-06-03

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

Phase 3 Terminated

52 enrolled 8 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hyperglycemia, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01236885 2015-04-23

Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant

Phase NA Completed

Hyperglycemia, Neoplasms

NCT01486043 2015-01-30

Metformin and Transient Hyperglycemia

Phase NA Terminated

4 enrolled 9 charts

LymphoidOther hematologic neoplasm

Diabetes Mellitus, Hyperglycemia, Insulin Resistance, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00943709 2013-08-30

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Phase 3 Withdrawn

LymphoidOther hematologic neoplasm

Congenital Abnormalities, Hyperglycemia, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma